Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?

Therapeutics and Clinical Risk Management

Volumn 5, Issue 1, 2009, Pages 491-498

  Baudel, Jean Luc ^a   Tankovic, Jacques ^a   Carrat, Fabrice ^b   Vigneau, Cécile ^a   Maury, Eric ^a,b   Lalande, Valérie ^a   Guidet, Bertrand ^a,b   Offenstadt, Georges ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Antimicrobial therapy; Appropriateness; Intensive care unit; Mortality

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; NITROIMIDAZOLE DERIVATIVE; OFLOXACIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPIRAMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; FEMALE; HOSPITAL; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; SIMPLIFIED ACUTE PHYSIOLOGY SCORE II; TREATMENT REFUSAL;

EID: 77949471806     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the inititiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122:262-268.
2. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 1998;113:412-420.
3. Luna CM, Vujacich P, Niedermann MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676-685.
4. Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196-200.
5. Bryan CS, Reynolds KL, Brenner ER. Analysis of 1186 episodes of Gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. Rev Infect Dis. 1983;5:629-638.
6. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-155.
7. Lodise TP, McKinnon PS, Swiderski L, et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003;36:1418-1423.
8. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742-2751.
9. Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529-535.
10. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-1596.
11. Leone M, Bourgoin A, Cambon S, et al. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med. 2003;21:462-467.
12. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108-121.
13. Montay V, Alfandari S, Senneville B, et al. Evaluation de la prescription antibiotique dans un service de réanimation polyvalente. Presse Médicale. 1998;27:700-704.
14. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 2001;29:1109-1115.
15. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-474.
16. Nseir S, Di Pompeo C, Soubrier S, et al. First-generation fluoroquinolone use and subsequent emergence of multidrug-resistant bacteria in the intensive care unit. Crit Care Med. 2005;33:289-289.
17. Reyes WJ, Brimioulle S, Vincent JL. Septic shock without documented infection: an uncommon entity with a high mortality. Intensive Care Med. 1999;25:1267-1270.